It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Neural stem/progenitor cells (NSPCs) originating from the subventricular zone (SVZ) contribute to brain repair during CNS disease. The microenvironment within the SVZ stem cell niche controls NSPC fate. However, extracellular factors within the niche that trigger astrogliogenesis over neurogenesis during CNS disease are unclear. Here, we show that blood-derived fibrinogen is enriched in the SVZ niche following distant cortical brain injury in mice. Fibrinogen inhibited neuronal differentiation in SVZ and hippocampal NSPCs while promoting astrogenesis via activation of the BMP receptor signaling pathway. Genetic and pharmacologic depletion of fibrinogen reduced astrocyte formation within the SVZ after cortical injury, reducing the contribution of SVZ-derived reactive astrocytes to lesion scar formation. We propose that fibrinogen is a regulator of NSPC-derived astrogenesis from the SVZ niche via BMP receptor signaling pathway following injury.
The molecular mechanisms regulating adult neural stem/progenitor cell differentiation following damage of the central nervous system are unclear. Here, the authors show that fibrinogen is a regulator of the adult neural stem/progenitor cell switch from neurogenesis to astrogenesis in a model of stroke
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Freiburg, Institute of Anatomy and Cell Biology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Faculty of Biology, Freiburg, Germany (GRID:grid.5963.9)
2 University of Freiburg, Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany (GRID:grid.5963.9)
3 Charité – Universitätsmedizin Berlin, Department of Neuropsychiatry & Laboratory of Molecular Psychiatry, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662)
4 University Medical Center Freiburg, University of Freiburg, Institute of Neuropathology, Freiburg, Germany (GRID:grid.6363.0)
5 State University of New York, Department of Pathology, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681)
6 University of Basel, Mattenstrasse 28, Department of Biomedicine, Embryology and Stem Cell Biology, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642)
7 Gladstone Institutes, San Francisco, USA (GRID:grid.249878.8) (ISNI:0000 0004 0572 7110); University of California San Francisco, Department of Neurology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
8 University of Freiburg, Institute of Anatomy and Cell Biology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)